Revenue
428 thousand USD
2025 Q1 · USD
Exact inputs and evidence
- Revenue: 428384 USD Source
Fundies. English
Fresh Harvest Products, Inc.
EDGARAnnual consolidated revenue for 2024: about USD 1.825M, using the latest reported figures. The previous period, 2023, was about USD 1.725M.
Latest quarter
Operating margin
-192.99%
2025 Q1 · %
Operating cash flow
30.9 thousand USD
2025 Q1 · USD
Exact inputs and evidence
- Operating Cash Flow: 30869 USD Source
Free cash flow
19.3 thousand USD
2025 Q1 · USD
- Cash and cash equivalents
- 125 thousand USD Source
Exact value
125390 USD
- Long-term debt including current maturities
- 319 thousand USD Source
Exact value
319014 USD
- Shares outstanding
- 59.8 million shares Source
Exact value
59838963 shares
Reported share-count change
150.56% · 36 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
1.77 million USD
2023-10-01 – 2024-09-30
Net income
1.27 million USD
2024-07-01 – 2025-06-30
Exact inputs and evidence
Operating cash flow
2.85 million USD
2024-07-01 – 2025-06-30
Exact inputs and evidence
- Operating cash flow: 30869 USD · 2024-07-01 – 2024-09-30 Source
- Operating cash flow: -75487 USD · 2024-07-01 – 2024-12-31 Source
- Operating cash flow: 30869 USD · 2024-07-01 – 2024-09-30 Source
- Operating cash flow: -93283 USD · 2024-07-01 – 2025-03-31 Source
- Operating cash flow: -75487 USD · 2024-07-01 – 2024-12-31 Source
- Operating cash flow: 2854212 USD · 2024-07-01 – 2025-06-30 Source
- Operating cash flow: -93283 USD · 2024-07-01 – 2025-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-01-08.
Financial data available through: 2024-06-30.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage by financial measure
- Revenue: 6 of 11 periods available· newest 2024-06-30
- Operating income: 6 of 11 periods available· newest 2024-06-30
- Net income: 6 of 11 periods available· newest 2024-06-30
- Operating cash flow: 6 of 11 periods available· newest 2024-06-30
- Capital expenditure: 3 of 11 periods available· newest 2024-06-30
- Total assets: 6 of 11 periods available· newest 2024-06-30
- Total liabilities: 6 of 11 periods available· newest 2024-06-30
- Current assets: 5 of 11 periods available· newest 2024-06-30
- Current liabilities: 6 of 11 periods available· newest 2024-06-30
- Cash and cash equivalents: 3 of 11 periods available· newest 2021-06-30
- Long-term debt including current maturities: 3 of 11 periods available· newest 2022-06-30
- Shares outstanding: 6 of 11 periods available· newest 2024-06-30
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+5.8%Prior period
USD 1.72 million
–
Current period
USD 1.82 million
–
Exact inputs and evidence
1824925 − 1724843 = 100082 USD
1724843 USD · 2022-07-01 – 2023-06-30
Inspect prior input Prior source1824925 USD · 2023-07-01 – 2024-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.29 millionPrior period
−USD 3.65 million
–
Current period
−USD 7.94 million
–
Exact inputs and evidence
-7938897 − -3647947 = -4290950 USD
-3647947 USD · 2022-07-01 – 2023-06-30
Inspect prior input Prior source-7938897 USD · 2023-07-01 – 2024-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 3.93 millionPrior period
−USD 168,972
–
Current period
−USD 4.09 million
–
Exact inputs and evidence
-4094816 − -168972 = -3925844 USD
-168972 USD · 2022-07-01 – 2023-06-30
Inspect prior input Prior source-4094816 USD · 2023-07-01 – 2024-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+302.4%Prior period
USD 12,592
–
Current period
USD 50,673
–
Exact inputs and evidence
50673 − 12592 = 38081 USD
12592 USD · 2022-07-01 – 2023-06-30
Inspect prior input Prior source50673 USD · 2023-07-01 – 2024-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2024 2023-07-01 – 2024-06-30
- Revenue USD 1.82 million 100% of revenue
- Operating costs Derived USD 5.83 million 319% of revenue
- Operating income −USD 4 million −219% of revenue
- Tax, interest and other Derived USD 3.94 million 216% of revenue
- Net income −USD 7.94 million −435% of revenue
Cash
- Operating cash flow −USD 4.09 million −224% of revenue
- Capital expenditure USD 50,673 2.8% of revenue
- Free cash flow Derived −USD 4.15 million −227% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2015 Not shown: operating income or net income is not reported.
- 2020 Not shown: operating income or net income is not reported.
- 2021 Operating loss: operating costs were 303% of revenue.
- 2022 Operating loss: operating costs were 1,507% of revenue.
- 2023 Operating loss: operating costs were 310% of revenue.
- 2024 Operating loss: operating costs were 319% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2015 2013-11-01 – 2014-10-31 | 0 | 335965 Derived | -335965 | 29379 Derived | -365344 | Unavailable | Source
|
| 2020 2019-07-01 – 2020-06-30 | 0 | 378371 Derived | -378371 | 111324 Derived | -489695 | Unavailable | Source
|
| 2021 2020-07-01 – 2021-06-30 | 349143 | 1058018 Derived | -708875 | 2556082 Derived | -3264957 | Unavailable | Source
|
| 2022 2021-07-01 – 2022-06-30 | 1297613 | 19555706 Derived | -18258093 | -199739 Derived | -18058354 | -629241 Derived | Source
|
| 2023 2022-07-01 – 2023-06-30 | 1724843 | 5349088 Derived | -3624245 | 23702 Derived | -3647947 | -181564 Derived | Source
|
| 2024 2023-07-01 – 2024-06-30 | 1824925 | 5828342 Derived | -4003417 | 3935480 Derived | -7938897 | -4145489 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 1.8M 2024
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Revenue | 0 |
|
| 2020 | Revenue | 0 |
|
| 2021 | Revenue | 349143 |
|
| 2022 | Revenue | 1297613 |
|
| 2023 | Revenue | 1724843 |
|
| 2024 | Revenue | 1824925 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
5.8% 2024
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Year over year | No prior comparable period |
|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | 271.7% |
|
| 2023 | Year over year | 32.9% |
|
| 2024 | Year over year | 5.8% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -219.4% 2024
Net margin -435% 2024
Free cash flow margin -227.2% 2024
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Operating margin | Not reported |
|
| 2020 | Operating margin | Not reported |
|
| 2021 | Operating margin | -203% |
|
| 2022 | Operating margin | -1,407.1% |
|
| 2023 | Operating margin | -210.1% |
|
| 2024 | Operating margin | -219.4% |
|
| 2015 | Net margin | Not reported |
|
| 2020 | Net margin | Not reported |
|
| 2021 | Net margin | -935.1% |
|
| 2022 | Net margin | -1,391.7% |
|
| 2023 | Net margin | -211.5% |
|
| 2024 | Net margin | -435% |
|
| 2015 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | -48.5% |
|
| 2023 | Free cash flow margin | -10.5% |
|
| 2024 | Free cash flow margin | -227.2% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -4.1M 2024
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Operating cash flow | -4392 |
|
| 2020 | Operating cash flow | -49243 |
|
| 2021 | Operating cash flow | 28100 |
|
| 2022 | Operating cash flow | -582878 |
|
| 2023 | Operating cash flow | -168972 |
|
| 2024 | Operating cash flow | -4094816 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -4.1M 2024
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | -629241 |
|
| 2023 | Free cash flow | -181564 |
|
| 2024 | Free cash flow | -4145489 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
941.1% 2024
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Liabilities / assets | 498,820.4% |
|
| 2020 | Liabilities / assets | 527,334.3% |
|
| 2021 | Liabilities / assets | 101.1% |
|
| 2022 | Liabilities / assets | 129.4% |
|
| 2023 | Liabilities / assets | 129.4% |
|
| 2024 | Liabilities / assets | 941.1% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.07× 2024
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014-10-31 | Current assets / current liabilities | Not reported |
|
| 2020 | Current assets / current liabilities | 0× |
|
| 2021 | Current assets / current liabilities | 0.24× |
|
| 2022 | Current assets / current liabilities | 0.13× |
|
| 2023 | Current assets / current liabilities | 0.11× |
|
| 2024 | Current assets / current liabilities | 0.07× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2013-11-01 – 2014-10-31 | −USD 365,344 Exact valueExact value: -365344 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4,392 Exact valueExact value: -4392 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-07-01 – 2020-06-30 | −USD 489,695 Exact valueExact value: -489695 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49,243 Exact valueExact value: -49243 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-07-01 – 2021-06-30 | −USD 3.26 million Exact valueExact value: -3264957 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 28,100 Exact valueExact value: 28100 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-07-01 – 2022-06-30 | −USD 18.06 million Exact valueExact value: -18058354 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 582,878 Exact valueExact value: -582878 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 46,363 Exact valueExact value: 46363 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 629,241 Calculation and evidence-582878 − 46363 USD Exact free cash flow: -629241 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-07-01 – 2023-06-30 | −USD 3.65 million Exact valueExact value: -3647947 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 168,972 Exact valueExact value: -168972 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 12,592 Exact valueExact value: 12592 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 181,564 Calculation and evidence-168972 − 12592 USD Exact free cash flow: -181564 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-07-01 – 2024-06-30 | −USD 7.94 million Exact valueExact value: -7938897 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.09 million Exact valueExact value: -4094816 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 50,673 Exact valueExact value: 50673 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.15 million Calculation and evidence-4094816 − 50673 USD Exact free cash flow: -4145489 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
65 filings · 1,707 latest values · 1,727 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001331612, 1331612, edgar:1331612
Also known as ANTIX HOLDINGS, INC., AnTix Holdings, Inc., Fresh Harvest Products, Inc., INNOVATIVE MEDTECH, INC., Innovative MedTech, Inc., Innovative Medtech, Inc., Serino 1, Corp., Serion 1, Corp.